Skip to content

Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor

TRANSCERVICAL FOLEY CATHETER (FOLEY) Versus INTRAVAGINAL MISOPROSTOL FOR CERVICAL RIPENING AND INDUCTION OF LABOR: A RANDOMIZED CLINICAL TRIAL.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01140971
Enrollment
180
Registered
2010-06-10
Start date
2006-01-31
Completion date
2009-01-31
Last updated
2010-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligohydramnios, Pre Eclampsia, Pregnancy, Prolonged

Keywords

Balloon dilatation,, misoprostol,, cervical ripening,, obstetric labor,, labor induced.

Brief summary

PURPOSE: The purpose of this study is to determine the effectiveness of balloon dilatation (Foley) with vaginal misoprostol for cervical ripening and induction of labor. METHOD: a randomized clinical assay has been performed with 160 women with indication of induction of labor, randomly divided in two groups, 80 for Foley catheter and 80 for misoprostol.

Detailed description

The cesarean delivery rate has risen dramatically in almost all world. Brazil shows the highest rate in the world so we need urgently efforts to reduce this fact. Several studies have shown that maternal morbidity and mortality rates are higher in cesarean deliveries. On the other hand an abdominal delivery cost much more than a vaginal delivery. A clinical trial to assess the performance of two simple and sheep methods can provide evidence based on local experience. Our results alow us to recommend both methods for clinical practice with a good possibility to reduce cesarean rates and without adverse events.

Interventions

DRUGMisoprostol

Vaginal application of 25 micrograms every 6 hours until cervical ripening reach Bishop 6 or more

DEVICEFoley

After Foley introduction, every 6 hours vaginal exam was performed. The cases on Bishop score increase or occurred spontaneous exit of catheter or spontaneous labour had been initiated are considered success.The failure was adopted if after48 hours occurred no cervical modifications.

Sponsors

Municipal Hospital Vila Nova Cachoeirinha
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Gestational age from 37 weeks, * feto unic, alive and cephalic, * Bishop index equal or lesser than four.

Exclusion criteria

* uterine scar, * premature rupture of the membranes, * fetal weight bigger than 4000 g, * previous placenta, * conditions that imposed the immediate ending of the gestation.

Design outcomes

Primary

MeasureTime frameDescription
Cervical ripening48 hous after start the methodFoley Group: catheter stay no more that 48 hours. Every 6 hours vaginal exam was performed. The cases on Bishop score increase or occurred spontaneous exit of catheter or spontaneous labour had been initiated are considered success.The failure was adopted if after48 hours occurred no cervical modifications. Misoprostol group: was introduced 25 microgram every 6 hour (max 200microg)if cervical conditions were unchanged. In the case of cervical evolution or start of labour the method was considered success.The failure was adopted if after 48 there was no cervical modifications.

Secondary

MeasureTime frameDescription
CesareanThe action of methods were assessed for 48 hours after start.After 48 hours if there was no cervical ripening or espontaneous labor the case was classified as failure of method and a cesarean was performed
Need of oxytocin48 hours after start methodIn cases on the cervical ripening had occurred but the spontaneous labor not start.
need of neonatal intensive care7 first days after birthThe condition of babies at birth and needs of intensive care as mechanic ventilation or others interventions.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026